4361 - 4370 of 7915 Results
Title
Year
- Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease2020OPENTitle: Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00370Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00370/pdfCitation Count: 9
-
OPENTitle: Revised Self-Monitoring ScaleJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009451Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357291Citation Count: 27
-
OPENTitle: Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in SpasticityJournal Name: ToxinsPublisher: MDPI AGVol: 12Issue #: 5Start Page: 292End Page: 292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/toxins12050292Best OA location URL: https://www.mdpi.com/2072-6651/12/5/292/pdf?version=1590147891Citation Count: 7
- The necroptosis pathway and its role in age-related neurodegenerative diseases: will it open up new therapeutic avenues in the next decade?2020RESTRICTEDTitle: The necroptosis pathway and its role in age-related neurodegenerative diseases: will it open up new therapeutic avenues in the next decade?Journal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 24Issue #: 7Start Page: 679End Page: 693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2020.1758668Citation Count: 14
- Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice2020RESTRICTEDTitle: Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practiceJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 5Start Page: 477End Page: 495Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1752669Citation Count: 29
-
OPENTitle: Serum triglycerides in Alzheimer diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009436Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526673Citation Count: 70
- A New Stimulation Mode for Deep Brain Stimulation in Parkinson's Disease: Theta Burst Stimulation2020RESTRICTEDTitle: A New Stimulation Mode for Deep Brain Stimulation in Parkinson's Disease: Theta Burst StimulationJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1471End Page: 1475Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28083Citation Count: 21
-
OPENTitle: All that’s fit to preprintJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 38Issue #: 5Start Page: 507End Page: 507Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41587-020-0536-xBest OA location URL: https://www.nature.com/articles/s41587-020-0536-x.pdfCitation Count: 10
- Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate2020OPENTitle: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidateJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 138Issue #:Start Page: 104789End Page: 104789Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104789Citation Count: 25
-
RESTRICTEDTitle: An Overview of the Current State and the Future of Ataxia TreatmentsJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 449End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220524Citation Count: 13